|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | |
| A61K 38/19 | |||
| A61K 38/20 | |||
| A61K 38/21 | |||
| A61F 2/16 | |||
| A61K 9/00 | |||
| A61K 35/30 | |||
| A61P 27/02 | |||
| A61P 27/06 |
| (11) | Number of the document | 3302524 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16729691.2 |
| Date of filing the European patent application | 2016-05-27 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/034552 |
| Date | 2016-05-27 |
| (87) | Number | WO 2016/191645 |
| Date | 2016-12-01 |
| (30) | Number | Date | Country code |
| 201562167213 P | 2015-05-27 | US |
| (72) |
GOLDBERG, Jeffrey, Louis, US
MCGOVERN, Cahil, US
TAO, Weng, US
KAUPER, Konrad, US
|
| (73) |
Neurotech USA, Inc.,
900 Highland Corporate Drive Building No. 1 Suite No. 101, Cumberland, RI 02864,
US
|
| (54) | USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF GLAUCOMA |
| USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF GLAUCOMA |